Shattuck Labs, a clinical-stage biotechnology company advancing its proprietary Agonist Redirected Checkpoint (ARC) platform to develop a novel class of biologic medicines for the treatment of cancer and other diseases, announced Casi Deyoung, MBA alumnus, has joined the company as Chief Business Officer.

Learn more about Casi here.